methyl-D-erythritol phosphate (MEP) or non-mevalonate pathway tagged posts

New class of Antibiotics active against a Wide Range of Bacteria

Dual-acting immuno-antibiotics block an essential pathway in bacteria and activate the adaptive immune response. Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial resistance (AMR). These finding were published today in Nature.

The World Health Organization (WHO) has declared AMR as one of the top 10 global public health threats against humanity. It is estimated that by 2050, antibiotic-resistant infections could claim 10 million lives each year and impose a cumulative $100 trillion burden on the global economy...

Read More